SYRE FY 2016 Earnings — Spyre Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SYRESpyre Therapeutics, Inc.

$3B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-23.9% YoY

Gross Profit

$00.0% margin

Operating Income

-$22M-473.3% margin

Net Income

-$22M-468.8% margin

EPS (Diluted)

$-55.40

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$67M

Total Liabilities

$4M

Stockholders' Equity

$63M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$6M	-23.9%
Gross Profit	$0	$0	—
Operating Income	-$22M	-$11M	-93.6%
Net Income	-$22M	-$11M	-92.1%